Table 1B.
Serum triamcinolone (μg/ML) | Urinary triamcinolone (μg/dL) | |||||||
---|---|---|---|---|---|---|---|---|
|
||||||||
Study subjects | baseline | week 1 | week 4 | week 12 | baseline | week 1 | week 4 | week 12 |
1 | 0 | 0.112 | 0 | 0 | 0 | 0.337 | 0.049 | 0 |
2 | 0 | 0.190 | 0.071 | 0.009 | 0 | 0.797 | 0.484 | 0.063 |
3 | 0 | 0.207 | 0.126 | 0 | 0 | 0.249 | 0.895 | 0.068 |
4 | 0 | 0.282 | 0.108 | 0 | 0 | 0.729 | 0.381 | 0.039 |
5 | 0 | 0.279 | 0.021 | 0.006 | 0 | 1.5 | 0.177 | 0.026 |
6 | 0 | 0.819 | 0 | 0 | 0 | 1.89 | 0.079 | 0 |
7 | 0 | 0.218 | 0.096 | 0 | 0 | 0.669 | 0.152 | 0 |
8 | 0 | 0.249 | 0 | 0 | 0 | 0.938 | 0.118 | 0 |
|
Drug levels were determined by mass spectrometry. Zero denotes undetectable.